Insulet (US:PODD) ZACKS·2025-11-06 13:40分组1 - Insulet reported quarterly earnings of $1.24 per share, exceeding the Zacks Consensus Estimate of $1.13 per share, and showing an increase from $0.9 per share a year ago, resulting in an earnings surprise of +9.73% [1] - The company achieved revenues of $706.3 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 4.42%, and up from $543.9 million year-over-year [2] - Insulet has consistently outperformed consensus EPS and revenue estimates over the last four quarters [2] 分组2 - The stock has gained approximately 20.4% since the beginning of the year, outperforming the S&P 500's gain of 15.6% [3] - The current consensus EPS estimate for the upcoming quarter is $1.32 on revenues of $727.16 million, and for the current fiscal year, it is $4.61 on revenues of $2.62 billion [7] - The Zacks Industry Rank indicates that the Medical - Products sector is currently in the bottom 40% of over 250 Zacks industries, which may impact stock performance [8]